肿瘤细胞治疗研究
英文原题:Pediatric extranasal, EBV-negative, extranodal natural killer/T-cell lymphoma; case report.
Pediatric extranasal, EBV-negative, extranodal natural killer/T-cell lymphoma; case report.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
结外自然杀伤/T细胞淋巴瘤(ENKTCL)是一种罕见的侵袭性肿瘤,主要发生于亚洲或美洲原住民血统的成年人。大多数与Epstein-Barr病毒(EBV)相关,并起源于鼻咽部。
我们报告一例婴儿暴发性、播散性、非鼻型、EBV阴性、看似新发的ENKTCL,表现为五天进行性腹胀、呼吸窘迫、易激惹、非胆汁性呕吐、右眼突出和苍白。初始实验室检查显示白细胞增多、贫血和血小板减少。计算机轴向断层扫描显示右侧视神经、上眼眶、胸腺、后纵隔、心包、心肌、腋窝淋巴结、肾上腺、肾脏和胰腺有密度影。患者迅速恶化,尽管进行了广泛复苏,最终死亡。尸检显示许多器官中有肿瘤,表现为血管损伤和组织坏死伴淋巴样浸润。
进一步组织学分析后确认了EBV阴性ENKTCL的可能诊断。儿童ENKTCL是一种特别罕见的肿瘤,尤其是考虑到我们的患者年龄非常小且EBV阴性。由于数据有限,确定这些儿童的最佳治疗方案具有挑战性。治疗通常包括联合化疗和放疗,但靶向治疗正在探索中,并取得了有希望的结果。
Extranodal natural killer/T-cell lymphomas (ENKTCL) are rare, aggressive neoplasms primarily occurring in adults of Asian or Native American descent. Most are associated with Epstein-Barr virus (EBV) and originate in the nasopharyngeal region.
We present the case of a fulminant, disseminated, non-nasal, EBV negative, seemingly de novo ENKTCL in an infant who presented with a five-day history of progressive abdominal distention, respiratory distress, irritability, non-bilious emesis, right eye proptosis, and pallor. Initial labs revealed leukocytosis, anemia and thrombocytopenia. Computerized axial tomography revealed densities in the right optic nerve, superior orbits, thymus, posterior mediastinum, pericardium, myocardium, axillary lymph nodes, adrenal glands, kidneys and pancreas. The patient rapidly deteriorated, and despite extensive resuscitation, ultimately died.
Autopsy revealed tumors in many organs, displaying vascular damage and tissue necrosis with lymphoid infiltration. The likely diagnosis of EBV-negative ENKTCL was confirmed after further histologic analysis. Pediatric ENKTCL is a particularly uncommon tumor, especially given our patient's very young age and EBV-negative status.
Determining the best treatment regimen for these children is challenging due to limited data. Treatment typically consists of combination chemotherapy and radiation, but targeted therapies are being explored with promising results.
MEMBER ACCOUNT
登录成功会直接打开下一页。